Brief: Results Of Single Center Study On Delcath’s Chemosat Hepatic Delivery System Published In Melanoma Research
03/02/2022 21:59
Feb 3 (Reuters) - Delcath Systems Inc DCTH.O :
* RESULTS OF SINGLE CENTER STUDY ON DELCATH’S CHEMOSAT®
HEPATIC
DELIVERY SYSTEM PUBLISHED IN MELANOMA RESEARCH
Source text for Eikon: ID:nGNX7HYyCl
Further company coverage: DCTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Delcath Systems
See all newsBrief: Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Delcath Systems Q1 revenue beats on Hepzato growth
Brief: Delcath Systems Announces Publication Of Chopin Clinical Trial Results In The Lancet Oncology
Delcath Q4 revenue rises 37%, beats estimates
Brief: Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)